25 XP   0   0   10

MedMira Inc
Buy, Hold or Sell?

Let's analyse Medmira together

PenkeI guess you are interested in MedMira Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of MedMira Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about MedMira Inc

I send you an email if I find something interesting about MedMira Inc.

Quick analysis of Medmira (30 sec.)










What can you expect buying and holding a share of Medmira? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.02
Expected worth in 1 year
C$-0.03
How sure are you?
7.1%

+ What do you gain per year?

Total Gains per Share
C$0.00
Return On Investment
-4.8%

For what price can you sell your share?

Current Price per Share
C$0.09
Expected price per share
C$0.08 - C$0.09
How sure are you?
50%

1. Valuation of Medmira (5 min.)




Live pricePrice per Share (EOD)

C$0.09

Intrinsic Value Per Share

C$-0.08 - C$-0.10

Total Value Per Share

C$-0.11 - C$-0.12

2. Growth of Medmira (5 min.)




Is Medmira growing?

Current yearPrevious yearGrowGrow %
How rich?-$11.6m-$8.9m-$1.7m-16.6%

How much money is Medmira making?

Current yearPrevious yearGrowGrow %
Making money-$519.7k-$363.5k-$156.1k-30.1%
Net Profit Margin-1,060.1%-292.1%--

How much money comes from the company's main activities?

3. Financial Health of Medmira (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#968 / 1031

Most Revenue
#641 / 1031

Most Profit
#216 / 1031

Most Efficient
#826 / 1031

What can you expect buying and holding a share of Medmira? (5 min.)

Welcome investor! Medmira's management wants to use your money to grow the business. In return you get a share of Medmira.

What can you expect buying and holding a share of Medmira?

First you should know what it really means to hold a share of Medmira. And how you can make/lose money.

Speculation

The Price per Share of Medmira is C$0.085. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medmira.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medmira, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.02. Based on the TTM, the Book Value Change Per Share is C$0.00 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medmira.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.00-1.0%0.00-0.9%0.00-0.6%0.00-0.6%0.00-0.6%
Usd Book Value Change Per Share0.00-1.0%0.00-0.9%0.001.0%0.00-0.2%0.00-0.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.00-1.0%0.00-0.9%0.001.0%0.00-0.2%0.00-0.7%
Usd Price Per Share0.07-0.07-0.09-0.10-0.08-
Price to Earnings Ratio-20.11--26.42--44.55--44.53--33.69-
Price-to-Total Gains Ratio-80.44--105.66--108.64--188.91--141.67-
Price to Book Ratio-3.97--4.70--6.97--6.44--5.09-
Price-to-Total Gains Ratio-80.44--105.66--108.64--188.91--141.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.0625855
Number of shares15978
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (15978 shares)-11.91-3.29
Gains per Year (15978 shares)-47.63-13.15
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-48-580-13-23
20-95-1060-26-36
30-143-1540-39-49
40-191-2020-53-62
50-238-2500-66-75
60-286-2980-79-88
70-333-3460-92-101
80-381-3940-105-114
90-429-4420-118-127
100-476-4900-132-140

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%1.019.00.05.0%1.027.00.03.6%1.027.00.03.6%
Book Value Change Per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%2.026.00.07.1%2.026.00.07.1%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.028.00.0%0.00.028.00.0%
Total Gains per Share0.04.00.00.0%1.011.00.08.3%2.018.00.010.0%2.026.00.07.1%2.026.00.07.1%

Fundamentals of Medmira

About MedMira Inc

MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis. It also provides Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics; and Reveal G4 HIV tests. In addition, the company offers VYRATM TriDemic antigen rapid test that distinguishes the three respiratory viruses, such as SARS-CoV-2, influenza, and respiratory syncytial virus that exhibit similar symptoms. It sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.

Fundamental data was last updated by Penke on 2024-03-10 22:26:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of MedMira Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medmira earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • A Net Profit Margin of -662.1% means that $-6.62 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of MedMira Inc:

  • The MRQ is -662.1%. The company is making a huge loss. -2
  • The TTM is -1,060.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-662.1%TTM-1,060.1%+398.0%
TTM-1,060.1%YOY-292.1%-768.0%
TTM-1,060.1%5Y-499.1%-561.0%
5Y-499.1%10Y-476.8%-22.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-662.1%-171.8%-490.3%
TTM-1,060.1%-205.8%-854.3%
YOY-292.1%-262.1%-30.0%
5Y-499.1%-455.6%-43.5%
10Y-476.8%-589.0%+112.2%
1.1.2. Return on Assets

Shows how efficient Medmira is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • -17.0% Return on Assets means that Medmira generated $-0.17 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of MedMira Inc:

  • The MRQ is -17.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -18.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-17.0%TTM-18.0%+1.0%
TTM-18.0%YOY-12.3%-5.7%
TTM-18.0%5Y-38.4%+20.4%
5Y-38.4%10Y-68.9%+30.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.0%-12.5%-4.5%
TTM-18.0%-12.2%-5.8%
YOY-12.3%-11.2%-1.1%
5Y-38.4%-13.4%-25.0%
10Y-68.9%-14.7%-54.2%
1.1.3. Return on Equity

Shows how efficient Medmira is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • 0.0% Return on Equity means Medmira generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of MedMira Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--15.8%+15.8%
TTM--15.7%+15.7%
YOY--13.9%+13.9%
5Y--18.3%+18.3%
10Y--19.2%+19.2%

1.2. Operating Efficiency of MedMira Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medmira is operating .

  • Measures how much profit Medmira makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of MedMira Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-235.6%+235.6%
TTM-5Y-199.2%+199.2%
5Y-199.2%10Y-230.0%+30.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--299.1%+299.1%
TTM--210.1%+210.1%
YOY-235.6%-279.7%+44.1%
5Y-199.2%-459.9%+260.7%
10Y-230.0%-596.9%+366.9%
1.2.2. Operating Ratio

Measures how efficient Medmira is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 6.48 means that the operating costs are $6.48 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of MedMira Inc:

  • The MRQ is 6.475. The company is inefficient in keeping operating costs low. -1
  • The TTM is 7.276. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.475TTM7.276-0.801
TTM7.276YOY3.586+3.691
TTM7.2765Y4.447+2.830
5Y4.44710Y4.615-0.168
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.4752.861+3.614
TTM7.2763.193+4.083
YOY3.5863.615-0.029
5Y4.4475.560-1.113
10Y4.6157.396-2.781

1.3. Liquidity of MedMira Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medmira is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.15 means the company has $0.15 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of MedMira Inc:

  • The MRQ is 0.154. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.124. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.154TTM0.124+0.029
TTM0.124YOY0.134-0.010
TTM0.1245Y0.088+0.036
5Y0.08810Y0.076+0.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1543.986-3.832
TTM0.1244.440-4.316
YOY0.1345.552-5.418
5Y0.0886.158-6.070
10Y0.0766.492-6.416
1.3.2. Quick Ratio

Measures if Medmira is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • A Quick Ratio of 0.08 means the company can pay off $0.08 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of MedMira Inc:

  • The MRQ is 0.079. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.085. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.079TTM0.085-0.005
TTM0.085YOY0.090-0.005
TTM0.0855Y0.053+0.031
5Y0.05310Y0.042+0.012
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0793.638-3.559
TTM0.0854.168-4.083
YOY0.0905.515-5.425
5Y0.0536.012-5.959
10Y0.0426.209-6.167

1.4. Solvency of MedMira Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medmira assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medmira to Biotechnology industry mean.
  • A Debt to Asset Ratio of 4.45 means that Medmira assets are financed with 444.8% credit (debt) and the remaining percentage (100% - 444.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of MedMira Inc:

  • The MRQ is 4.448. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 4.715. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ4.448TTM4.715-0.266
TTM4.715YOY4.022+0.692
TTM4.7155Y11.262-6.548
5Y11.26210Y15.402-4.140
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4480.335+4.113
TTM4.7150.330+4.385
YOY4.0220.267+3.755
5Y11.2620.367+10.895
10Y15.4020.378+15.024
1.4.2. Debt to Equity Ratio

Measures if Medmira is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medmira to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of MedMira Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.376-0.376
TTM-0.398-0.398
YOY-0.334-0.334
5Y-0.429-0.429
10Y-0.476-0.476

2. Market Valuation of MedMira Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Medmira generates.

  • Above 15 is considered overpriced but always compare Medmira to the Biotechnology industry mean.
  • A PE ratio of -20.11 means the investor is paying $-20.11 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of MedMira Inc:

  • The EOD is -18.992. Based on the earnings, the company is expensive. -2
  • The MRQ is -20.109. Based on the earnings, the company is expensive. -2
  • The TTM is -26.416. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-18.992MRQ-20.109+1.117
MRQ-20.109TTM-26.416+6.307
TTM-26.416YOY-44.547+18.131
TTM-26.4165Y-44.527+18.110
5Y-44.52710Y-33.689-10.838
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-18.992-2.643-16.349
MRQ-20.109-2.418-17.691
TTM-26.416-2.742-23.674
YOY-44.547-4.123-40.424
5Y-44.527-6.257-38.270
10Y-33.689-6.478-27.211
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of MedMira Inc:

  • The EOD is -21.615. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -22.886. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -63.108. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-21.615MRQ-22.886+1.271
MRQ-22.886TTM-63.108+40.222
TTM-63.108YOY190.419-253.527
TTM-63.1085Y79.646-142.754
5Y79.64610Y50.816+28.830
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-21.615-3.244-18.371
MRQ-22.886-2.939-19.947
TTM-63.108-3.478-59.630
YOY190.419-5.592+196.011
5Y79.646-8.473+88.119
10Y50.816-8.881+59.697
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medmira is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -3.97 means the investor is paying $-3.97 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of MedMira Inc:

  • The EOD is -3.749. Based on the equity, the company is expensive. -2
  • The MRQ is -3.970. Based on the equity, the company is expensive. -2
  • The TTM is -4.704. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.749MRQ-3.970+0.221
MRQ-3.970TTM-4.704+0.734
TTM-4.704YOY-6.969+2.264
TTM-4.7045Y-6.441+1.737
5Y-6.44110Y-5.088-1.353
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-3.7492.124-5.873
MRQ-3.9702.041-6.011
TTM-4.7042.118-6.822
YOY-6.9692.915-9.884
5Y-6.4413.682-10.123
10Y-5.0884.114-9.202
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of MedMira Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.001-0.001-10%0.001-197%0.000-75%-0.001-28%
Book Value Per Share---0.023-0.021-8%-0.017-23%-0.020-10%-0.019-18%
Current Ratio--0.1540.124+24%0.134+15%0.088+75%0.076+103%
Debt To Asset Ratio--4.4484.715-6%4.022+11%11.262-61%15.402-71%
Debt To Equity Ratio----0%-0%-0%-0%
Dividend Per Share----0%-0%-0%-0%
Eps---0.001-0.001-10%-0.001-37%-0.001-39%-0.001-34%
Free Cash Flow Per Share---0.001-0.001-41%-0.001-40%-0.001-43%-0.001-47%
Free Cash Flow To Equity Per Share--0.0010.000+301%0.000+128%0.000+108%0.000+106%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.100--------
Intrinsic Value_10Y_min---0.084--------
Intrinsic Value_1Y_max---0.003--------
Intrinsic Value_1Y_min---0.003--------
Intrinsic Value_3Y_max---0.015--------
Intrinsic Value_3Y_min---0.014--------
Intrinsic Value_5Y_max---0.033--------
Intrinsic Value_5Y_min---0.030--------
Market Cap59282911.360-6%62770141.44068000986.560-8%83693521.920-25%93283404.640-33%71239128.777-12%
Net Profit Margin---6.621-10.601+60%-2.921-56%-4.991-25%-4.768-28%
Operating Margin----0%-2.3560%-1.9920%-2.3000%
Operating Ratio--6.4757.276-11%3.586+81%4.447+46%4.615+40%
Pb Ratio-3.749+6%-3.970-4.704+18%-6.969+76%-6.441+62%-5.088+28%
Pe Ratio-18.992+6%-20.109-26.416+31%-44.547+122%-44.527+121%-33.689+68%
Price Per Share0.085-6%0.0900.098-8%0.120-25%0.134-33%0.102-12%
Price To Free Cash Flow Ratio-21.615+6%-22.886-63.108+176%190.419-112%79.646-129%50.816-145%
Price To Total Gains Ratio-75.969+6%-80.437-105.664+31%-108.635+35%-188.912+135%-141.668+76%
Quick Ratio--0.0790.085-6%0.090-11%0.053+49%0.042+90%
Return On Assets---0.170-0.180+6%-0.123-28%-0.384+126%-0.689+305%
Return On Equity----0%-0%-0%-0%
Total Gains Per Share---0.001-0.001-10%0.001-197%0.000-75%-0.001-28%
Usd Book Value---11642386.645-10748426.407-8%-8967959.497-23%-10429247.462-10%-9529790.188-18%
Usd Book Value Change Per Share---0.001-0.001-10%0.001-197%0.000-75%-0.001-28%
Usd Book Value Per Share---0.017-0.015-8%-0.013-23%-0.015-10%-0.014-18%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.001-0.001-10%-0.001-37%-0.001-39%-0.001-34%
Usd Free Cash Flow---504863.239-295962.044-41%-304969.938-40%-286785.316-43%-265309.165-47%
Usd Free Cash Flow Per Share---0.0010.000-41%0.000-40%0.000-43%0.000-47%
Usd Free Cash Flow To Equity Per Share--0.0010.000+301%0.000+128%0.000+108%0.000+106%
Usd Market Cap43650007.634-6%46217655.14250069126.404-8%61623540.190-25%68684570.836-33%52453370.519-12%
Usd Price Per Share0.063-6%0.0660.072-8%0.088-25%0.098-33%0.075-12%
Usd Profit---574579.068-519748.464-10%-363551.070-37%-352142.323-39%-380876.078-34%
Usd Revenue--86781.79179082.486+10%160280.729-46%181808.669-52%163497.387-47%
Usd Total Gains Per Share---0.001-0.001-10%0.001-197%0.000-75%-0.001-28%
 EOD+2 -6MRQTTM+10 -20YOY+6 -245Y+9 -2110Y+9 -21

3.2. Fundamental Score

Let's check the fundamental score of MedMira Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-18.992
Price to Book Ratio (EOD)Between0-1-3.749
Net Profit Margin (MRQ)Greater than0-6.621
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.079
Current Ratio (MRQ)Greater than10.154
Debt to Asset Ratio (MRQ)Less than14.448
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-0.170
Total1/10 (10.0%)

3.3. Technical Score

Let's check the technical score of MedMira Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.012
Ma 20Greater thanMa 500.089
Ma 50Greater thanMa 1000.096
Ma 100Greater thanMa 2000.098
OpenGreater thanClose0.085
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-10-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets4,586
Total Liabilities20,398
Total Stockholder Equity-15,812
 As reported
Total Liabilities 20,398
Total Stockholder Equity+ -15,812
Total Assets = 4,586

Assets

Total Assets4,586
Total Current Assets2,682
Long-term Assets1,904
Total Current Assets
Cash And Cash Equivalents 892
Net Receivables 1,386
Inventory 176
Total Current Assets  (as reported)2,682
Total Current Assets  (calculated)2,454
+/- 227
Long-term Assets
Property Plant Equipment 1,904
Long-term Assets  (as reported)1,904
Long-term Assets  (calculated)1,904
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities17,458
Long-term Liabilities2,940
Total Stockholder Equity-15,812
Total Current Liabilities
Short Long Term Debt 6,146
Accounts payable 3,234
Total Current Liabilities  (as reported)17,458
Total Current Liabilities  (calculated)9,380
+/- 8,078
Long-term Liabilities
Long term Debt 1,135
Capital Lease Obligations Min Short Term Debt1,978
Long-term Liabilities  (as reported)2,940
Long-term Liabilities  (calculated)3,112
+/- 172
Total Stockholder Equity
Total Stockholder Equity (as reported)-15,812
Total Stockholder Equity (calculated)0
+/- 15,812
Other
Capital Stock68,350
Common Stock Shares Outstanding 697,446
Net Debt 6,389
Net Invested Capital -8,534
Net Working Capital -14,776



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-10-312023-07-312023-04-302023-01-312022-10-312022-07-312022-04-302022-01-312021-10-312021-07-312021-04-302021-01-312020-10-312020-07-312020-04-302020-01-312019-10-312019-07-312019-04-302019-01-312018-10-312018-07-312018-04-302018-01-312017-10-312017-07-312017-04-302017-01-31
> Total Assets 
816
699
674
619
348
277
301
289
324
275
253
2,665
2,832
3,098
3,396
4,560
3,999
3,679
3,890
4,868
4,554
4,098
3,830
3,777
3,724
3,829
3,652
4,586
4,5863,6523,8293,7243,7773,8304,0984,5544,8683,8903,6793,9994,5603,3963,0982,8322,665253275324289301277348619674699816
   > Total Current Assets 
674
582
581
551
302
245
272
271
310
266
246
130
344
656
911
2,123
1,610
1,342
1,576
2,603
2,340
1,874
1,658
1,658
1,658
1,816
1,692
2,682
2,6821,6921,8161,6581,6581,6581,8742,3402,6031,5761,3421,6102,123911656344130246266310271272245302551581582674
       Cash And Cash Equivalents 
119
94
156
119
27
0
0
0
0
1
89
0
155
423
402
603
122
5
0
995
937
396
33
15
125
84
13
892
8921384125153339693799505122603402423155089100002711915694119
       Net Receivables 
194
204
172
187
40
19
73
76
79
46
39
15
70
44
208
1,130
1,106
1,013
1,251
1,302
1,099
1,200
1,369
1,390
1,298
1,342
1,261
1,386
1,3861,2611,3421,2981,3901,3691,2001,0991,3021,2511,0131,1061,13020844701539467976731940187172204194
       Inventory 
281
254
227
211
211
204
182
182
182
171
106
104
102
110
223
339
291
252
236
224
218
235
202
193
185
179
182
176
176182179185193202235218224236252291339223110102104106171182182182204211211227254281
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
9
7
2,534
2,488
2,442
2,485
2,437
2,389
2,337
2,314
2,265
2,214
2,224
2,171
2,119
2,066
2,013
1,960
1,904
1,9041,9602,0132,0662,1192,1712,2242,2142,2652,3142,3372,3892,4372,4852,4422,4882,53479000000000
       Property Plant Equipment 
142
117
92
68
46
33
29
19
13
9
7
2,534
2,488
2,442
2,485
2,437
2,389
2,337
2,314
2,265
2,214
2,224
2,171
2,119
2,066
2,013
1,960
1,904
1,9041,9602,0132,0662,1192,1712,2242,2142,2652,3142,3372,3892,4372,4852,4422,4882,5347913192933466892117142
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000000
> Total Liabilities 
8,504
9,138
9,658
10,158
10,601
11,173
11,699
12,203
12,867
13,331
13,769
16,650
17,432
18,391
18,958
19,408
19,247
19,265
19,614
21,084
16,035
15,991
16,186
16,765
17,203
17,898
18,683
20,398
20,39818,68317,89817,20316,76516,18615,99116,03521,08419,61419,26519,24719,40818,95818,39117,43216,65013,76913,33112,86712,20311,69911,17310,60110,1589,6589,1388,504
   > Total Current Liabilities 
8,218
8,401
9,421
10,158
10,601
11,173
11,699
12,203
12,867
13,331
13,769
14,233
15,053
16,009
15,806
16,300
16,763
17,026
17,415
18,912
13,905
13,901
14,138
14,393
14,631
14,886
15,726
17,458
17,45815,72614,88614,63114,39314,13813,90113,90518,91217,41517,02616,76316,30015,80616,00915,05314,23313,76913,33112,86712,20311,69911,17310,60110,1589,4218,4018,218
       Short-term Debt 
6,244
6,642
5,967
6,189
6,202
6,207
6,160
6,158
8,199
8,250
8,610
8,734
9,307
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000009,3078,7348,6108,2508,1996,1586,1606,2076,2026,1895,9676,6426,244
       Short Long Term Debt 
6,244
6,642
5,967
6,189
6,202
6,207
6,160
6,158
8,199
8,250
8,610
8,734
9,307
9,442
8,621
8,582
9,105
9,131
9,192
9,184
6,121
6,114
6,100
6,102
6,152
6,145
6,145
6,146
6,1466,1456,1456,1526,1026,1006,1146,1219,1849,1929,1319,1058,5828,6219,4429,3078,7348,6108,2508,1996,1586,1606,2076,2026,1895,9676,6426,244
       Accounts payable 
2,125
2,337
1,602
1,628
1,789
1,873
1,917
1,867
2,432
2,653
2,480
2,473
1,502
1,510
1,289
1,387
1,303
1,452
2,700
2,608
2,454
2,570
2,750
2,832
2,719
2,844
3,263
3,234
3,2343,2632,8442,7192,8322,7502,5702,4542,6082,7001,4521,3031,3871,2891,5101,5022,4732,4802,6532,4321,8671,9171,8731,7891,6281,6022,3372,125
       Other Current Liabilities 
76
94
247
268
312
428
546
537
657
744
823
84
1,010
1,687
2,322
2,515
2,401
2,344
1,234
1,054
863
639
612
646
808
0
0
0
0008086466126398631,0541,2342,3442,4012,5152,3221,6871,010848237446575375464283122682479476
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
2,417
2,379
2,382
3,152
3,108
2,484
2,239
2,199
2,172
2,131
2,089
2,048
2,372
2,572
3,012
2,957
2,940
2,9402,9573,0122,5722,3722,0482,0892,1312,1722,1992,2392,4843,1083,1522,3822,3792,41700000000000
       Other Liabilities 
0
49
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000490
> Total Stockholder Equity
-7,690
-8,442
-8,987
-9,542
-10,256
-10,898
-11,401
-11,916
-12,543
-13,056
-13,517
-13,986
-14,600
-15,292
-15,562
-14,847
-15,248
-15,586
-15,724
-16,215
-11,482
-11,893
-12,356
-12,988
-13,479
-14,069
-15,032
-15,812
-15,812-15,032-14,069-13,479-12,988-12,356-11,893-11,482-16,215-15,724-15,586-15,248-14,847-15,562-15,292-14,600-13,986-13,517-13,056-12,543-11,916-11,401-10,898-10,256-9,542-8,987-8,442-7,690
   Common Stock
63,419
63,419
63,419
63,419
63,419
63,419
63,419
63,419
63,419
63,419
63,419
63,419
63,419
63,419
63,419
63,419
63,434
63,434
63,902
63,899
68,347
68,347
68,347
68,347
68,347
68,347
0
0
0068,34768,34768,34768,34768,34768,34763,89963,90263,43463,43463,41963,41963,41963,41963,41963,41963,41963,41963,41963,41963,41963,41963,41963,41963,41963,419
   Retained Earnings -98,739-97,959-96,996-96,406-95,916-95,283-94,820-94,409-93,941-93,452-92,815-92,477-92,061-92,776-92,506-91,814-91,199-90,731-90,282-89,770-89,140-88,624-88,122-87,465-86,751-86,115-85,557-84,805
   Capital Surplus 0000000000000000000000000000
   Treasury Stock0000000000000000000000000000
   Other Stockholders Equity 
13,696
13,696
13,708
13,790
13,790
13,804
13,804
13,804
13,804
13,804
13,792
13,792
13,792
13,792
13,792
13,792
13,792
13,792
13,824
13,824
14,578
14,578
14,578
14,578
0
0
0
0
000014,57814,57814,57814,57813,82413,82413,79213,79213,79213,79213,79213,79213,79213,79213,80413,80413,80413,80413,80413,79013,79013,70813,69613,696



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-07-31)

Gross Profit (+$)
totalRevenue433
Cost of Revenue-132
Gross Profit300300
 
Operating Income (+$)
Gross Profit300
Operating Expense-2,211
Operating Income-1,778-1,910
 
Operating Expense (+$)
Research Development471
Selling General Administrative1,039
Selling And Marketing Expenses0
Operating Expense2,2111,509
 
Net Interest Income (+$)
Interest Income0
Interest Expense-886
Other Finance Cost-12
Net Interest Income-898
 
Pretax Income (+$)
Operating Income-1,778
Net Interest Income-898
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,676-1,778
EBIT - interestExpense = -886
-2,676
-1,790
Interest Expense886
Earnings Before Interest and Taxes (EBIT)0-1,790
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-2,676
Tax Provision-0
Net Income From Continuing Ops-2,676-2,676
Net Income-2,676
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0898
 

Technical Analysis of Medmira
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medmira. The general trend of Medmira is BEARISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medmira's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-71.4%) Bearish trend (71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of MedMira Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.09 < 0.09 < 0.09.

The bearish price targets are: 0.08 > 0.08 > 0.08.

Tweet this
MedMira Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of MedMira Inc. The current mas is .

The long score for the Moving Averages is 2/14.
The longshort score for the Moving Averages is -10/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

MedMira Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of MedMira Inc. The current macd is -0.00353677.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medmira price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Medmira. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Medmira price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
MedMira Inc Daily Moving Average Convergence/Divergence (MACD) ChartMedMira Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of MedMira Inc. The current adx is 52.92.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Medmira shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
MedMira Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of MedMira Inc. The current sar is 0.09051979.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
MedMira Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of MedMira Inc. The current rsi is 42.01. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
MedMira Inc Daily Relative Strength Index (RSI) ChartMedMira Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of MedMira Inc. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 3/(-6 +6).

  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Medmira price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
MedMira Inc Daily Stochastic Oscillator ChartMedMira Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of MedMira Inc. The current cci is -81.08108108.

MedMira Inc Daily Commodity Channel Index (CCI) ChartMedMira Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of MedMira Inc. The current cmo is -14.74848292.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
MedMira Inc Daily Chande Momentum Oscillator (CMO) ChartMedMira Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of MedMira Inc. The current willr is -50.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Medmira is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
MedMira Inc Daily Williams %R ChartMedMira Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of MedMira Inc.

MedMira Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of MedMira Inc. The current atr is 0.00519736.

MedMira Inc Daily Average True Range (ATR) ChartMedMira Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of MedMira Inc. The current obv is 1,591,367.

MedMira Inc Daily On-Balance Volume (OBV) ChartMedMira Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of MedMira Inc. The current mfi is 30.63.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
MedMira Inc Daily Money Flow Index (MFI) ChartMedMira Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for MedMira Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-14CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-17WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-11-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-13SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-22CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-10MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside

6.3. Candlestick Patterns

MedMira Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of MedMira Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.012
Ma 20Greater thanMa 500.089
Ma 50Greater thanMa 1000.096
Ma 100Greater thanMa 2000.098
OpenGreater thanClose0.085
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Medmira with someone you think should read this too:
  • Are you bullish or bearish on Medmira? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medmira? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about MedMira Inc

I send you an email if I find something interesting about MedMira Inc.


Comments

How you think about this?

Leave a comment

Stay informed about MedMira Inc.

Receive notifications about MedMira Inc in your mailbox!